Chicago, IL and Southfield, MI – CFI USA is pleased to announce that they served as Rhythmlink’s exclusive M&A advisor and lead a broad sale process.
Founded in 2002, Rhythmlink is a leading full-service designer, manufacturer, and distributor of neurodiagnostic devices, consumables, and solutions for clinicians, external service providers, and OEM partners. Rhythmlink owns a patent protected portfolio of innovative and technically superior product solutions. The Company is the market leader in disposable devices for intraoperative monitoring and is leading a market conversion to disposable devices for EEG and cEEG monitoring.
New Heritage Capital is a Boston-based private equity firm with a twenty-year history of partnering with growing, middle market, founder-owned businesses. With its innovative investment structures like the Private IPO®, Heritage provides founders with a combination of liquidity and growth capital while allowing founders to maintain control of their business. With decades of experience at managing growth, Heritage gives its partners the strategic, operational and financial guidance to help its companies reach their growth objectives.
acquired the shares it did not already own in
Bioforce AG (Switzerland), which develops and produces phytopharmaceuticals, nutraceuticals and food supplements, acquired the shares it did not already own in the joint venture with Bioforce Denmark A/S (Denmark), which is the exclusive distributor of Bioforce products
has been sold to
Careflex Zorg Groep, the largest independent external healthcare provider for complex care with a proven and distinct BPO proposition in the Benelux, has been sold to Bolster Investment Partners
acquired a majority stake in
Ergon Capital Partners has acquired a majority stake in Indo Optical, a leading Spanish independent manufacturer of ophtalmic lenses and distributor of optical and ophtalmologic equipment
has made a collection of Euro 50 million in form of Acquistion Financing
CEF, a leading italian wholesale distirbutor of pharmaceuticals products to Italian pharmacies, has made a collection of Euro 50 million in form of Acquistion Financing.